Role of skeletal muscle in the syndrome of chronic heart failure

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 11, 1996, Pages 2275-2285

  Poole Wilson, Philip A ^a   Ferrari, R ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHROPOMETRY; HEART FAILURE; HEART HEMODYNAMICS; HUMAN; LUNG FUNCTION; LUNG HEMODYNAMICS; MUSCLE BIOPSY; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; SYMPTOM;

EID: 0030296906     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0220     Document Type: Review

References (120)

1. ANAND AS, VEALL N, KABRA GS, FERRARI R, SUTTON G, LIPKIN D, HARRIS P, POOLE-WILSON PA, 1989. Treatment of heart failure with diuretics: body compartments, renal function and plasma hormones. Eur Heart J 10: 445-450.
2. ASMUSSEN E, NIELSEN M, 1964. Experiments on nervous factors controlling respiration and circulation during exercise employing blocking of the blood flow. Acta Physiol Scand 60: 103-111.
3. BAKER BJ, WILEN MM, BOYD CM, DINH HA, FRANCIOSA JA, 1984. Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure. Am J Cardiol 54: 596-599.
4. BELCH JJF, BRIDGES AB, SCOTT N, CHOPRA M, 1991. Oxygen free radicals and congestive heart failure. Br Heart J 65: 245-248.
5. BERSIN R, KWASMAN M, WOLFE C, DE MARCO T, LAU D, KLINSKI C, GOLONKA J, CHATTERJEE K, 1990. Improved hemodynamic function in congestive heart failure with the metabolic agent sodium dichloroacetate (DCA). (Abstract). J Am Coll Cardiol 15: 157A.
6. BITTNER V, WEINER DH, YUSUF S, ROGERS WJ, MCINTYRE KM, BANGDIWALA SI, KRONENBERG MW, KOSTIS JB, KOHN RM, GUILOTTE M, GREENBERG B, WOODS PA, BOURASSA MG, 1993. For the SOLVD investigators. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA 270: 1702-1707.
7. BLACKBURN G, GIBBONS G, BOTHE A, BENOTTI P, HARKEN D, MCENANY T, 1977. Nutritional support in cardiac cachexia. J Thorac Cardiovasc Surg 73: 489-796.
8. BROWN CC JR, FRY DL, EBERT RV, 1954. The mechanism of pulmonary ventilation in patient with heart disease. Am J Med 17: 438-446.
9. BULLER NP, POOLE-WILSON PA, 1990. Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure. Br Heart J 63: 281-283.
10. BULLER NP, JONES D, POOLE-WILSON PA, 1991. Direct measurements of skeletal muscle fatigue in patients with chronic heart failure. Br Heart J 65: 20-24.
11. CAFORIO ALP, ROSSI B, RISALTI R, SICILIANO G, MARCHETTI A, ANGNELLI C, CREA F, MARIANI M, MURATORIO A, 1989. Type 1 fibre abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: Evidence of subclinical myogenic myopathy. J Am Coll Cardiol 14: 1464-1473.
12. CARR J, STEVENSON L, WALDEN J, HEBER D, 1989. Prevalence and haemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. Am J Cardiol 63: 709-713.
13. CLARK AL, COATS AJS, 1992. The mechanisms underlying the increased ventilatory response to exercise in chronic stable heart failure. Eur Heart J 13: 1698-1708.
14. CLARK AL, POOLE-WILSON PA, COATS AJS, 1992. The relationship between ventilation and carbon dioxide production in patients with chronic heart failure. J Am Cardiol 71: 1007-1008.
15. CLARK AL, PIEPOLI M, COATS AJ, 1993. Evidence for skeletal muscle metabolic receptors driving ventilation on exercise. Circulation 88: I-415.
16. CLARK AL, VOLTERRANI M, PIEPOLI M, POOLE-WILSON PA, COATS AJS, 1993. The influence of stage duration during incremental treadmill exercise on metabolic gas exchange measurements. Eur Heart J 14 [Suppl.]: 417.
17. CLARK AL, VOLTERRANI M, CERQUETARI E, LUDMAN P, SWAN JW, POOLE-WILSON PA, COATS AJS, 1995. The relationship between arterial potassium and ventilation during exercise in patients with chronic heart failure. J Heart Failure 1: 133-141.
18. CLARK AL, SWAN JW, LANEY R, CONNELLY M, SOMERVILLE J, COATS AJS, 1994. The role of right and left ventricular function in the ventilatory response to exercise in chronic heart failure. Circulation 89: 2062-2069.
19. CLARK AL, COATS AJSS, 1994. Usefulness of arterial blood gas estimations during exercise in patients with chronic heart failure. Br Heart J 41: 528-530.
20. CLARK AL, PIEPOLI M, COATS AJS, 1994. Skeletal muscle and the control of ventilation on exercise; evidence for metabolic receptors. Eur J Clin Invest, in press.
21. COATS AJS, ADAMOPOULOS S, RADAELLI A, MCCANCE A, MEYER TE, BERNARDI L, SOLDA PL, DAVEY P, ORMEROD O, FORFAR C, CONWAY J, SLEIGHT P, 1992. Controlled trial of physical training in chronic heart failure: exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 85: 2119-2131.
22. COATS AJS, CLARK AL, PIEPOLI M, VOLTERRANI M, POOLE-WILSON PA, 1994. Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J 72: S36-S39.
23. COOKSEY JD, REILLY P, BROWN S, BOMZE H, CRYER PE, 1978. Exercise training and plasma catecholamines in patients with ischemic heart disease. Am J Cardiol 42: 372-376.
24. COMINI L, BACHETTI T, GAIA G, PASINI E, AGNOLETTI L, PEPI P, CECONI C, CURELLO S, FERRARI R, 1996. Aorta and skeletal muscle NO-synthase expression in experimental heart failure. J Mol Cell Cardiol, in press.
25. DAVEY P, MEYER T, COATS A, ADAMOPOULOS S, CASADEI B, CONWAY J, SLEIGHT P, 1992. Ventilation in chronic heart failure: effects of physical training. Br Heart J 68: 473-477.
26. DAVIS SW, BAILEY J, KEEGAN J, BALCON R, RUDD RM, LIPKIN DP, 1992. Reduced pulmonary microvascular permeability in severe chronic heart failure. Am Heart J 124: 137-142.
27. DAVIES SW, EMERY TM, WATLING MIL, WANNAMETHEE G, LIPKIN DP, 1991. A critical threshold of exercise capacity in the ventilatory response to exercise in heart failure. Br Heart J 65: 179-183.
28. DE GIULI F, CARGNONI A, PASINI E, MAZZOLETTI A, CONFORTINI R, ANAND I, FERRARI R, 1994. Effect of propionyl-1-carnitine (PLC) on skeletal muscle metabolism in patients with chronic heart failure (chronic heart failure). (Abstract). Can J Cardiol 10: 74.
29. DREXLER H, RIEDE U, SCHAFER H, 1987. Reduced oxidative capacity of skeletal muscle in patients with severe heart failure. (Abstract). Circulation 76: IV-178.
30. DREXLER H, RIEDE U, HIROI M, MUNZEL T, HOLUBARSCH C, MEINERTZ T, 1988. Ultrastructural analysis of skeletal muscle in chronic heart failure: Relation to exercise capacity and indices of left ventricular dysfunction. (Abstract). Circulation 78: II-107.
31. DREXLER H, BANHARDT U, MEINERTZ T, WOLLSCHLAGER H, LEHMANN M, JUST H, 1989. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patient with congestive heart failure. A double-blind, placebo-controlled trial. Circulation 79: 491-502.
32. DREXLER H, 1992. Skeletal muscle failure in heart failure. Circulation 85: 1621-1623.
33. DREXLER H, REIDE U, MUNZEL T, KONIG H, FUNKE E, JUST H, 1992. Alterations of skeletal muscle in chronic heart failure. Circulation 85: 1751-1759.
34. DUNNIGAN A, STALEY NA, SMITH SA, PIERPONT ME, JUDD D, BENDITT DG, BENSON DW, 1987. Cardiac and skeletal muscle abnormalities in cardiomyopathy: comparison of patients with ventricular tachycardia or congestive heart failure. J Am Coll Cardiol 10: 608-618.
35. DZAU VJ, 1992. Role of endothelium-derived vasoactive substances in the regulation of vascular tone via structural remodeling of blood vessels. In: Ryan US, Rubanyi GM, eds, Endothelial Regulation of Vascular Tone. New York: Marcel Dekker, 331-339.
36. FERGUSON DW, BERG WJ, SANDERS JS, 1990. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol 16: 1125-1134.
37. FERRARI R, BERNOCCHI P, BORASO A, VISIOLI O, 1993. Insufficienza cardiaca congestizia dal muscolo cardiaco al muscolo scheletrico. Cardiologia 38: 45-50.
38. FERRARI R, BACHETTI T, CONFORTINI R, OPASICH C, FEBO O, CORTI A, CASSANI G, VISIOLI O, 1995. Tumor necrosis factors soluble receptors in patients with various degrees of congestive heart failure. Circulation 92: 1479-1486.
39. FERRARI R, COMINI L, BACHETTI T, AGNOLETTI L, GAIA G, MILANESI B, VOLTERRANI M, D'ALOIA A, GIORDANO A, CORTI A, 1996. Expression of inducible NO-synthase in the monocytes and tumor necrosis factor activation in patients with congestive heart failure. Circulation, in press.
40. FINK LI, WILSON JR, FERRARO N, 1986. Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure. Am J Cardiol 57: 248-253.
41. FRANCIOSA JA, PARK M, LEVINE TB, 1981. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 47: 33-39.
42. FRANCIOSA JA, LEDDY CL, WILEN M, SCHWARTZ DE, 1984. Relation between haemodynamic and ventilatory responses in determining exercise capacity in severe congestive heart failure. Am J Cardiol 35: 127-134.
43. FRANCIOSA JA, BAKER BJ, SETHL, 1985. Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure. Am Heart J 110: 807-813.
44. GADSBOLL N, HOILAND-CARLSON PF, BADSBERG JH, 1991. Cardiac function and maximal exercise capacity early after acute myocardial infarction. Eur Heart J 12: 1189-1194.
45. GIBBS JSR, KEEGAN J, WRIGHT C, FOX KM, POOLE-WILSON PA, 1990. Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure. J Am Coll Cardiol 15: 52-61.
46. GREEN HJ, THOMSON JA, DAUB BD, RANNEY DA, 1980. Biochemical and histochemical alterations in skeletal muscle in man during a period of reduced activity. Can J Physiol Pharmacol 58: 1311-1316.
47. GREEN HJ, SUTTON JR, CYMERMAN A, YOUNG PM, HOUSTON CS, 1989. Operation Everest II: adaptations in human skeletal muscle. J Appl Physiol 66: 2454-2461.
48. 2 output during exercise in chronic heart failure. Circulation 84: 605-612.
49. HESPEL P, LIJNEN P, FAGGARD R, VAN HOOF R, GOOSSENS W, LISSENS W, MOERMAN E, AMERY A, 1988. Effects of physical endurance training on the plasma reninangiotensin-aldosterone system in normal man. J Endocrinol 116: 443-449.
50. HIGGINBOTHAM MB, MORRIS KG, CONN EH, COLEMAN RE, COBB FR, 1983. Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am J Cardiol 51: 52-60.
51. HOH H, TANIGUCHI K, KOIKE A, DOI M, 1990. Evaluation of severity of heart failure using ventilatory gas analysis. Circulation 81 [Suppl. 21] : 31-37.
52. HOLLOSZY JO, 1976. Adaptations of muscular tissue to training. Prog Cardiovasc Dis 18: 445-458.
53. HOLLOSZY JO, COYLE EF, 1984. Adaptation of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 56: 831-838.
54. JONDEAU G, KATZ SD, ZOHMAN L, GOLBERGER M, MCCARTHY M, BOURDARIAS J-P, LEJEMTEL TH, 1992. Active skeletal muscle mass and cardiopulmonary reserve: failure to attain peak aerobic capacity during maximal bicycle exercise in patient with severe congestive heart failure. Circulation 86: 1351-1356.
55. KATZ AM, KATZ PB, 1962. Disease of the heart in works of Hippocrates. Br Heart J 24: 256-264.
56. KATZ SD, SCHWARZ M, YUEN J, LEJEMTEL TH, 1993. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation 88: 55-61.
57. KATZ SK, BLEIBERG B, WEXLER J, BHARGAVA K, STEINBERG JJ, LEJEMTEL T, 1993. Lactate turnover at rest and during submaximal exercise in patients with heart failure. J Appl Physiol 75: 1974-1979.
58. KETEYIAN S, SHEPARD R, EHRMAN J, FEDEL F, GLICK C, RHOADS K, LEVINE TB, 1991. Cardiovascular response of heart transplant patients to exercise training. J Appl Physiol 70: 2627-2631.
59. LEJEMTEL TH, MASKIN CS, LUCIDO D, CHADWICK BJ, 1989. Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure. Circulation 80: 769-781.
60. LEVINE B, KALMAN J, MAYER LM, FILLIT H, PACKER M, 1990. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 232: 236-241.
61. LIM M, LINTON RAF, WOLFF CB, BAND DM, 1981. Propranolol, exercise and arterial plasma potassium. Lancet ii: 591.
62. LIPKIN DP, CANEPA-ANSON R, STEPHENS MR, POOLE-WILSON PA, 1986. Factors determining symptoms in heart failure: comparison of fast and slow exercise tests. Br Heart J 1986; 55: 439-445.
63. LIPKIN DP, POOLE-WILSON PA, 1986. Symptoms limiting exercise in chronic heart failure. Br Mol J 292: 1030-1031.
64. LIPKIN DP, JONES DA, ROUND JM, POOLE-WILSON PA, 1988. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 18: 187-195.
65. MANCINI DM, FERRARO N, TUCHLER M, CHANCE B, WILSON JR, 1988. Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance. Am J Cardiol 62: 1234-1240.
66. MANCINI DM, COYLE E, COGGAN A, BELTZ J, FERRARO N, MONTAIN S, WILSON JR, 1989. Contribution of intrinsic skeletal muscle changes to 31P-NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 80: 1338-1346.
67. MANCINI DM, WALTER G, REICHEK N, LENKINSKI R, MCCULLY KK, MULLEN JL, WILSON JR, 1992. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85: 1364-1373.
68. MARTINEAU L, HORAN MA, ROTHWELL N, LITTLE RA, 1992. Salbutamol, a β2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin Sci 83: 615-621.
69. MARZO K, HERRMANN HA, REIN A, MANCINI D, 1991. Acute effect of balloon mitral valvuloplasty on exercise capacity ventilation and skeletal muscle oxygenation. Circulation 84 [Suppl. II]: II-72.
70. MASKIN CS, FORMAN R, SONNENBLICK EH, FRISHMAN WH, LEJEMTEL TH, 1983. Failure of dobutamine to increase exercise capacity despite haemodynamic improvement in severe chronic heart failure. Am J Cardiol 51: 177-182.
71. MASSIE BM, KRAMER B, HAUGHOM F, 1981. Acute and long-term effects of vasodilator therapy on resting and exercise hemodynamics and exercise tolerance. Circulation 64: 1218-1226.
72. MASSIE BM, CONWAY M, YONGE R, FROSTICK S, LEDINGHAM J, SLEIGHT P, RADDA G, RAJAGOPALAN B, 1987. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 76: 1009-1019.
73. MCCLOSKEY DI, MITCHELL JH, 1972. Reflex cardiovascular and respiratory responses originating in exercising muscle. J Physiol 224: 173-187.
74. MCMURRAY J, ABDULLAH I, DARGIE HJ, SHAPIRO D, 1991. Increased concentrations of tumour necrosis factor in "cachetic" patients with severe chronic heart failure. Br Heart J 66: 356-358.
75. METRA M, DEI CAS L, PANINA G, VISIOLI O, 1992. Exercise hyperventilation chronic congestive heart failure and its relation to function capacity and hemodynamics. Am J Cardiol 70: 622-628.
76. MINOTTI JR, CHRISTOPH I, OKA R, WINER MW, WELLS L, MASSIE BM, 1991. Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance. J Clin Invest 88: 2077-2282.
77. MINOTTI JR, PILLAY P, CHANG L, WELLS L, MASSIE BM, 1992. Neurophysiological assessment of skeletal muscle fatigue in patients with congestive heart failure. Circulation 86: 903-908.
78. MINOTTI JR, PILLAY P, OKA R, WELLS L, CHRISTOPH I, MASSIE BM, 1993. Skeletal muscle size: relationship to muscle function in heart failure. J Appl Physiol 75: 373-381.
79. MOHSENIFAR Z, AMIN DK, SHAH PK, 1989. Regional distribution of lung perfusion and ventilation in patients with chronic congestive heart failure and its relationship to cardiopulmonary hemodynamics. Am Heart J 117: 887-891.
80. MOORE DP, GILLIGAN D, OAKLEY CM, 1989. Hypocapnia during exercise testing in dilated cardiomyopathy and hypertrophic cardiomyopathy: objective assessment by respiratory gas analysis. Br Heart J 61: 435.
81. MORRISON WL, GIBSON JNA, RENNIE MJ, 1988. Skeletal muscle and whole body protein turnover in cardiac cachexia: influence of branched chain amino acid administration. Eur J Clin Invest 18: 648-654.
82. NOAKES T, 1988. Implications of exercise testing for prediction of athletic performance: a contemporary perspective. Med Sci Sports Exerc 20: 319-330.
83. PACKER M, 1990. Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure. Circulation 81 [Suppl. III]: 78-86.
84. PATEL A, RAZZACK Z, DASTIR D, 1969. Disuse atrophy of human skeletal muscles. Arch Neurol 20: 413-421.
85. PATERSON DJ, ROBBINS PA, CONWAY J, 1989. Changes in arterial plasma potassium and ventilation during exercise in man. Resp Physiol 78: 323-330.
86. PATERSON DJ, FRIEDLAND JS, BASCOM DA, CLEMENT ID, CUNNINGHAM DA, PAINTER R, ROBBINS PA, 1990. Changes in arterial K+ and ventilation during exercise in normal subjects and patients with McArdle's syndrome. J Physiol 429: 339-348.
87. PITMAN J, COHEN P, 1964. The pathogenesis of cardiac cachexia. N Engl J Med 271: 403-409, 453-460.
88. POOLE-WILSON PA, 1988. The origin of symptoms in patients with chronic heart failure. Eur Heart J9 [Suppl. H]: 49-53.
89. POOLE-WILSON PA, BULLER NP, LINDSAY DC, 1992. Blood flow and skeletal muscle in patients with heart failure. Chest 101: 330S-3302.
90. RAJFER SA, NEMANICH JW, SHURMAN AJ, ROSSEN JD, 1987. Metabolic responses to exercise in patients with heart failure. Circulation 76 [Suppl. VI]: 46-53.
91. REDDY HK, WEBER KT, JANICKI JS, MCELROY PA, 1988. Hemodynamic, ventilatory and metabolic effects of light isometric exercise in patients with chronic heart failure. J A Coll Cardiol 12: 53-58.
92. REFENBERICK DH, GAMBLE JG, MAX SR, 1973. Response of mitochondrial enzymes to decreased muscular activity. Am J Physiol 225: 1295-1259.
93. RUBIN SA, BROWN HV, SWAN HJC, 1982. Arterial oxygenation and arterial oxygen transport in chronic myocardial failure at rest, during exercise and after hydralazine treatment. Circulation 66: 143-148.
94. RUBIN SA, BROWN HV, 1984. Ventilation and gas exchange during exercise in severe chronic heart failure. Am Rev Respir Dis 129 [Suppl.]: S63-S64.
95. SAVIN WM, HASKELL WL, SCHROEDER JS, STINSON EB, 1980. Cardiorespiratory responses of cardiac transplant patients to graded, symptom-limited exercise. Circulation 62: 55-60.
96. SINOWAY L, MINOTTI J, MUSCH T, et al. 1987. Enhanced metabolic vasodilation secondary to diuretic therapy in decompensated congestive heart failure secondary to coronary artery disease. Am J Cardiol 60: 107-111.
97. SINOWAY LI, MINITTI JR, DAVIS D, PENNOCK JL, BURG JE, MUSCH TI, ZELIS R, 1988. Delayed reversal of impaired vasodilation in congestive heart failure after heart transplantation. Am J Cardiol 61: 1076-1079.
98. SULLIVAN MJ, HIGGINBOTHAM MB, COBB FR, 1988. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite haemodynamic and pulmonary abnormalities. Circulation 77: 552-559.
99. SULLIVAN MJ, KNIGHT JD, HIGGINBOTHAM MB, COBB FR, 1989. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation 80: 769-781.
100. SULLIVAN MJ, COBB FR, 1990. The anaerobic threshold in chronic heart failure. Circulation 81 [Suppl. II]: II47-II58.
101. SWAN JW, WALTON C, GODSLAND IF, CLARK AL, COATS AJS, 1994. Insulin resistance in chronic heart failure. Eur Heart J 15: 1528-1532.
102. SZLACHCIC J, MASSIE BM, KRAMER BL, TOPIC N, TUBAU J, 1985. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 55: 1037-1042.
103. TIBES U, HEMMER B, BONING D, 1977. Heart rate and ventilation in relation to venous (K+), osmolality pH, PCO2, PO2, (orthophosphate), and (lactate) at transition from rest to exercise in athletes and non-athletes. Eur J Appl Physiol 36: 127-140.
104. UREN NG, DAVIES SW, AGNEW JE, IRWIN AG, JORDAN SL, HILSON AJW, LIPKIN DP, 1993. Reduction of mismatch of global ventilation and perfusion on exercise is related to exercise capacity in chronic heart failure. Eur Heart J 70: 241-246.
105. VOLTERRANI M, CLARK AL, LUDMAN PF, SWAN JW, ADAMOPULOS S, PIEPOLI M, COATS AJS, 1994. Determinants of exercise capacity in chronic heart failure. Eur Heart J 15: 801-809.
106. WADA O, ASANOI H, MIYAGI K, ISHIZAKA S, KAMEYAMA T, SETO H, SASAYAMA S, 1993. Importance of abnormal lung perfusion in excessive exercise ventilation in chronic heart failure. Am Heart J 125: 790-798.
107. WARGOVICH TJ, MACDONALD RG, HILL JA, FELDMAN RL, STACPOOLE PW, PEPINE CJ, 1988. Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease. Am J Cardiol 61: 65-70.
108. WEBER KT, KINASEWITZ GT, JANICKI JS, FISHMAN AP, 1982. Oxygen utilisation and ventilation during exercise in patient with chronic cardiac failure. Circulation 65: 1213-1223.
109. WEBER KT, WILSON JR, JANICKI J, LIKOFF MJ, 1984. Exercise testing in the evaluation of the patient with chronic cardiac failure. Am Rev Respir Dis 129 [Suppl]: S60-S62.
110. WEBER KT, JANICKI JS, 1985. Lactate production during maximal and submaximal exercise in patients with chronic heart failure. J Am Coll Cardiol 6: 717-724.
111. WIENER DH, FINK LI, MARIS J, JONES RA, CHANCE B, WILSON JR, 1986. Abnormal skeletal muscle bioenergetics during exercise in heart failure: role of reduced muscle blood flow. Circulation 73: 1127-1136.
112. WILSON JR, FERRARO N, 1985. Effect of the renin-angiotensin system on limb circulation and metabolism during exercise in heart failure. J Am Coll Cardiol 6: 556-563.
113. WILSON JR, FINK L, MARIS J, et al, 1985a. Evaluation of skeletal muscle energy metabolism in patients with heart failure using gated phosphorus-31 nuclear magnetic resonance. Circulation 71: 57-62.
114. WILSON JR, FERRARO N, WIENER DH, 1985b. Effect of the sympathetic nervous system on limb circulation and metabolism during exercise in heart failure. Circulation 72: 72-81.
115. WILSON JR, MANCINI DM, FERRARO N, EGLER J, 1988. Effect of dichloroacetate on the exercise performance of patients with heart failure. J Am Coll Cardiol 12: 1464-9.
116. WILSON JR, MANCINI DM, SIMSON M, 1992. Detection of skeletal muscle fatigue in patients with heart failure using electromyography. Am J Cardiol 70: 488-493.
117. WILSON JR, MANCINI OM, 1993. Factors contributing to the exercise limitation of heart failure. JACC 22: 93A-8.
118. WILSON JR, 1993. Exertional fatigue in chronic heart failure. Circulation 87: 470.
119. YEH MP, GARDNER MR, ADAMS TD, YANOWITZ FG, CRAPO RO, 1983. Anaerobic threshold: problems of determination and validation. J Appl Physiol 55: 1178-1186.
120. ZELIS R, FLAIM SF, 1982. Alterations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis 1982; 24: 437-59.